Can you explain the roles and clinical significance of dehydroepiandrosterone sulfate (DHEA‑S), estradiol, follicle‑stimulating hormone (FSH), luteinizing hormone (LH), and sex hormone‑binding globulin (SHBG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Overview of Key Sex Hormones and Binding Proteins

These five hormones and proteins form the core diagnostic framework for evaluating reproductive endocrine function, with each serving distinct physiological roles and providing specific clinical information when measured together.

DHEA-S (Dehydroepiandrosterone Sulfate)

DHEA-S is an adrenal androgen that serves as the primary marker for adrenal androgen production and helps distinguish adrenal from ovarian sources of hyperandrogenism 1.

Physiological Role

  • Produced predominantly (>95%) by the adrenal cortex
  • Functions as a precursor hormone that converts peripherally to more potent androgens (testosterone, DHT) and estrogens
  • Levels decline progressively with age in both sexes
  • In postmenopausal women, DHEA-S becomes a major substrate for peripheral estrogen production 2

Clinical Significance

  • Elevated DHEA-S specifically indicates adrenal androgen excess, distinguishing it from ovarian hyperandrogenism 1, 3
  • In PCOS evaluation, DHEA-S levels tend to be high-normal or elevated, particularly in normal-weight women 1
  • Useful for ruling out adrenal tumors or late-onset congenital adrenal hyperplasia when markedly elevated
  • Critical caveat: Assays are not standardized across laboratories—familiarity with local reference ranges is essential 1
  • Shows positive correlation with ovarian reserve markers in infertility workup 4

Estradiol (E2)

Estradiol is the most potent endogenous estrogen and the principal intracellular human estrogen, serving as the primary marker of ovarian follicular function 5.

Physiological Role

  • Secreted by ovarian follicles: 70-500 mcg daily depending on menstrual cycle phase 5
  • Acts through nuclear estrogen receptors to regulate reproductive tissue development and maintenance
  • Modulates pituitary gonadotropin (LH/FSH) secretion via negative feedback 5
  • Post-menopause: produced mainly from peripheral conversion of adrenal androgens 5

Clinical Significance

  • Low estradiol (<50 pg/mL) with elevated gonadotropins indicates ovarian insufficiency/menopause 1
  • Low estradiol (<50 pg/mL) with low gonadotropins suggests functional hypothalamic amenorrhea or pituitary dysfunction 1
  • In PCOS, estradiol is typically <50 pg/mL despite anovulation 1
  • Circulates bound to SHBG (primary) and albumin; only free fraction is biologically active 5
  • Estrogen administration increases thyroid-binding globulin and SHBG, requiring thyroid dose adjustments in hypothyroid patients 5

FSH (Follicle-Stimulating Hormone)

FSH is the pituitary gonadotropin that drives follicular development and serves as the primary marker for ovarian reserve and function.

Physiological Role

  • Secreted by anterior pituitary in response to hypothalamic GnRH
  • Stimulates ovarian follicle growth and granulosa cell estradiol production
  • Subject to negative feedback by estradiol and inhibin B 5

Clinical Significance

  • Elevated FSH (>15 IU/L) indicates diminished ovarian reserve or primary ovarian insufficiency 1
  • Low FSH (<10 IU/L) with amenorrhea suggests functional hypothalamic amenorrhea, PCOS, or pituitary/hypothalamic pathology 1
  • In functional hypothalamic amenorrhea: FSH <10 IU/L with low estradiol 1
  • In PCOS: FSH <10 IU/L with LH/FSH ratio >1 (LH predominance) 1
  • In menopause/ovarian failure: FSH >15 IU/L with FSH > LH pattern 1
  • Critical for distinguishing between central (hypothalamic/pituitary) versus peripheral (ovarian) causes of amenorrhea

LH (Luteinizing Hormone)

LH is the pituitary gonadotropin that triggers ovulation and drives ovarian androgen production, with its ratio to FSH providing diagnostic information for PCOS.

Physiological Role

  • Secreted by anterior pituitary in pulsatile fashion regulated by GnRH
  • Triggers ovulation at mid-cycle surge
  • Stimulates ovarian theca cells to produce androgens (testosterone, androstenedione)
  • Subject to negative feedback by estradiol and progesterone 5

Clinical Significance

  • Elevated LH with LH/FSH ratio >1 suggests PCOS (though not required for diagnosis) 1
  • In PCOS: LH <15 IU/L but elevated relative to FSH, with LH/FSH ratio typically >1 1
  • Low LH (<10 IU/L) indicates functional hypothalamic amenorrhea or central hypogonadism 1
  • Elevated LH (>15 IU/L) with elevated FSH indicates ovarian insufficiency 1
  • LH drives ovarian stromal androgen production—suppression with estrogen therapy reduces testosterone 6

SHBG (Sex Hormone-Binding Globulin)

SHBG is the primary transport protein for sex steroids that determines bioavailable hormone levels and serves as an inverse marker of insulin resistance and androgenicity.

Physiological Role

  • Hepatically-produced glycoprotein that binds testosterone and estradiol with high affinity
  • Only unbound (free) hormones are biologically active 5
  • Binds testosterone > estradiol > other steroids
  • Levels inversely correlate with insulin and androgens; positively correlate with estrogens

Clinical Significance

  • Low SHBG increases free (bioavailable) testosterone even when total testosterone is normal—this is the most sensitive indicator of hyperandrogenism in PCOS 1, 3
  • Estrogen therapy increases SHBG by 160%, dramatically reducing bioavailable testosterone 6
  • Androgens and insulin suppress SHBG production 3
  • In PCOS: SHBG is typically normal or elevated (high-normal range) 1
  • Measuring both total testosterone AND SHBG (or calculating free testosterone) is essential—total testosterone alone misses many cases of biochemical hyperandrogenism 1
  • SHBG decreases with DHEA supplementation 2, 7

Integrated Diagnostic Patterns

Functional Hypothalamic Amenorrhea

  • LH <10, FSH <10, LH/FSH ≈1
  • Estradiol <50 pg/mL
  • Low-normal DHEA-S, testosterone, SHBG 1

PCOS

  • LH <15, FSH <10, LH/FSH >1 (LH predominance)
  • Estradiol <50 pg/mL
  • High-normal or elevated DHEA-S and testosterone
  • Normal or elevated SHBG 1

Primary Ovarian Insufficiency/Menopause

  • LH >15, FSH >15, FSH > LH
  • Estradiol <50 pg/mL
  • Low-normal testosterone and DHEA-S 1

Key Clinical Pitfalls

  • Always interpret hormones in context of local assay reference ranges—lack of standardization is a major limitation 1
  • Timing matters: Measure on cycle day 2-5 for accurate baseline assessment in cycling women
  • Free or bioavailable testosterone is more sensitive than total testosterone for detecting hyperandrogenism 1
  • SHBG alterations change interpretation: High SHBG (from estrogen therapy) lowers free testosterone despite stable total levels 5, 6
  • Prolactin and TSH must be checked concurrently to exclude hyperprolactinemia and thyroid dysfunction 1

References

1
Guideline

functional hypothalamic amenorrhea: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2017

3
Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

7
Research

Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.

The aging male : the official journal of the International Society for the Study of the Aging Male, 2004

Related Questions

Can elevated testosterone cause hair loss in an adult female with high ferritin levels?
Is the patient's elevated total and free testosterone contributing to her diffuse hair loss?
How should hair loss be evaluated and managed in a patient with elevated dehydroepiandrosterone (DHEA) levels?
In a woman with hair loss and elevated dehydroepiandrosterone sulfate (DHEAS), what is the appropriate work‑up and management?
In a 26-year-old woman with mildly elevated serum testosterone, normal dehydroepiandrosterone (DHEA), estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, and thyroid-stimulating hormone (TSH), who presents with oligomenorrhea (period every 56 days) and a negative pregnancy test, what is the most likely diagnosis and first-line management?
What are the mechanisms by which Enterococcus species resist ampicillin?
Can you briefly summarize the abortion guidelines in Canada?
What are the causes of narrowed medial knee joint space in a 31‑year‑old female pickleball player?
What is the appropriate medical management and surveillance strategy for a patient with an ectatic aortic root?
Which MTAP antibody clone/brand is used for immunohistochemistry in variant carcinoma research?
What are the possible causes of pain on the bottom of the foot?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.